Meridian Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.02M Sell
14,732
-760
-5% -$52.5K 0.04% 306
2025
Q1
$1.08M Sell
15,492
-7,885
-34% -$548K 0.05% 279
2024
Q4
$2.01M Sell
23,377
-103,509
-82% -$8.9M 0.1% 185
2024
Q3
$15.1M Buy
+126,886
New +$15.1M 0.74% 23
2024
Q2
Sell
-96,386
Closed -$12.4M 465
2024
Q1
$12.4M Buy
96,386
+42,385
+78% +$5.44M 2.06% 9
2023
Q4
$5.59M Sell
54,001
-9,921
-16% -$1.03M 0.36% 63
2023
Q3
$5.81M Buy
63,922
+30,062
+89% +$2.73M 0.36% 54
2023
Q2
$2.74M Buy
33,860
+22,680
+203% +$1.84M 0.23% 95
2023
Q1
$890K Sell
11,180
-174
-2% -$13.8K 0.08% 224
2022
Q4
$768K Buy
11,354
+5,394
+91% +$365K 0.08% 235
2022
Q3
$297K Sell
5,960
-2,510
-30% -$125K 0.03% 370
2022
Q2
$472K Buy
+8,470
New +$472K 0.04% 362
2019
Q3
Sell
-1,820
Closed -$464 385
2019
Q2
$464 Buy
+1,820
New +$464 0.02% 382